MISSISSAUGA, ON, March 19, 2020 - On Wednesday, March 11, the World Health Organization (WHO) declared a pandemic in response to the COVID-19 outbreak. This is a serious health situation and we extend our sympathies to all who have lost loved ones, to patients, and healthcare professionals. We recognize that the public and private sectors across the globe need to work together to help effectively manage this quickly evolving situation.
Roche Canada recognizes that addressing a pandemic of this magnitude requires the contributions of all members of the healthcare ecosystem and community.
We are currently working with Health Canada, Public Health Agency of Canada (PHAC) and provincial public labs to align strategy for available COVID-19 testing solutions, including those provided by Roche, according to the needs of various jurisdictions. We are diligently providing our solutions for COVID-19 testing to laboratories and we are taking the necessary measures to help reduce the level of pandemic impact.
Considering the high demand for this testing globally, we are working with our global supply chain and authorities to ensure that supplies are distributed to provincial laboratories and designated high priority institutions. Roche Canada will continue to follow federal agency and public health laboratory guidelines for direct procurement for these tests.
While there are currently no approved therapeutic options for the treatment of COVID-19, Roche is actively involved in understanding the potential of our existing portfolio. We are pleased to confirm that Canada has been selected as a participant in a Phase III clinical trial studying the safety and efficacy of one of our portfolio medicines in hospitalized adult patients with severe COVID-19 pneumonia. In addition, Roche is also collecting and compiling data from other, independently-led clinical trials that are taking place around the world.
Roche advocates that people follow the steps outlined by the
- 30 -
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
You are now leaving the website of Hoffmann-La Roche Ltd. ("Roche Canada"). Links to all external sites are provided as a resource to our visitors. Roche Canada assumes no responsibility for the content of these sites. Roche Canada has no control over these sites and the opinions, claims or comments contained in these sites should not be attributed to Roche Canada, unless otherwise specified.